Wednesday, December 19, 2012

SR9238 compound can reverse effects of fatty liver disease

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.

URL: http://www.news-medical.net/news/20121220/SR9238-compound-can-reverse-effects-of-fatty-liver-disease.aspx

No comments:

Post a Comment